(Updated - September 25, 2015 7:25 AM EDT)

(Update included ticker for GLPG)AbbVie (NYSE: ABBV), a global biopharmaceutical company ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News FDA Hot Corp. News Management Comments

Cowen Remains Bullish on Galapagos NV (GLPG) After AbbVie (ABBV) Declined to Opt-In for Phase III Development of Filgotinib September 25, 2015 3:14 PM Galapagos NV (GLPG) to Advance Filgotinib to Phase 3 in Rheumatoid ArthritisSeptember 25, 2015 10:51 AM AbbVie to Advance Once-Daily ABT-494 to Phase 3 in Rheumatoid Arthritis by Year-EndSeptember 25, 2015 7:13 AM